These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38543207)

  • 1. An Analytical Target Profile for the Development of an In Vitro Release Test Method and Apparatus Selection in the Case of Semisolid Topical Formulations.
    Szoleczky R; Kovács A; Berkó S; Budai-Szűcs M
    Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Apparatus and Adapter on In vitro Drug Release of Ophthalmic Semisolid Drug Products.
    Mekjaruskul C; O'Reilly Beringhs A; Qin B; Wang Y; Chowdhury P; Lu X
    Pharm Res; 2023 Sep; 40(9):2239-2251. PubMed ID: 37679656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical Quality by Design (AQbD) Approach to the Development of In Vitro Release Test for Topical Hydrogel.
    Szoleczky R; Budai-Szűcs M; Csányi E; Berkó S; Tonka-Nagy P; Csóka I; Kovács A
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive approach to qualify and validate the essential parameters of an in vitro release test (IVRT) method for acyclovir cream, 5.
    Tiffner KI; Kanfer I; Augustin T; Raml R; Raney SG; Sinner F
    Int J Pharm; 2018 Jan; 535(1-2):217-227. PubMed ID: 28935255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the hanson microette and the Van Kel apparatus for in vitro release testing of topical semisolid formulations.
    Rapedius M; Blanchard J
    Pharm Res; 2001 Oct; 18(10):1440-7. PubMed ID: 11697470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. aQbD as a platform for IVRT method development - A regulatory oriented approach.
    Miranda M; Pais AACC; Cardoso C; Vitorino C
    Int J Pharm; 2019 Dec; 572():118695. PubMed ID: 31536762
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kulkarni M; Potdar S; Date AA; Marfatiya A
    Assay Drug Dev Technol; 2021; 19(2):75-84. PubMed ID: 33035072
    [No Abstract]   [Full Text] [Related]  

  • 8. A comprehensively validated IVRT method reliably discriminates sameness and differences between several topical clotrimazole creams.
    Wellington H; Rath S; Kanfer I
    Eur J Pharm Sci; 2024 Jan; 192():106649. PubMed ID: 37992910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of optimal in vitro release and permeation testing method for rectal suppositories.
    Srivatsa Palakurthi S; Bharat Charbe N; Recalde Phillips SY; Alge DL; Lu D; Palakurthi S
    Int J Pharm; 2023 Jun; 640():123042. PubMed ID: 37178789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Drug Release Testing Method For Nepafenac Ophthalmic Suspension.
    Gupta PK; Pancholi SS; Das P
    J Pharm Sci; 2024 Apr; 113(4):1061-1067. PubMed ID: 38042345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester.
    McKinney RD; Dunbar JR
    Int J Pharm Compd; 2021; 25(3):241-245. PubMed ID: 34125715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Discriminative In Vitro Release Test for Rivastigmine Transdermal Patches Using Pharmacopeial Apparatuses: USP 5 and USP 6.
    Simon A; Amaro MI; Healy AM; Cabral LM; de Sousa VP
    AAPS PharmSciTech; 2017 Oct; 18(7):2561-2569. PubMed ID: 28224389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Validated IVRT Method to Assess Topical Creams Containing Metronidazole Using a Novel Approach.
    Rath S; Kanfer I
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028557
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Medina-López R; Guillén-Moedano S; Hurtado M
    ADMET DMPK; 2020; 8(4):411-423. PubMed ID: 35300193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel modified vertical diffusion cell for testing of
    Sebe I; Zsidai L; Zelkó R
    HardwareX; 2022 Apr; 11():e00293. PubMed ID: 35509921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling and comparison of release profiles: Effect of the dissolution method.
    Cascone S
    Eur J Pharm Sci; 2017 Aug; 106():352-361. PubMed ID: 28627469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Drug Release Modeling Across Dissolution Apparatuses I and II using Computational Fluid Dynamics.
    Kubinski AM; Shivkumar G; Georgi RA; George S; Reynolds J; Sosa RD; Ju TR
    J Pharm Sci; 2023 Mar; 112(3):808-819. PubMed ID: 36336104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life cycle management of analytical methods.
    Parr MK; Schmidt AH
    J Pharm Biomed Anal; 2018 Jan; 147():506-517. PubMed ID: 28666555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of different test parameters on in vitro drug release from topical diclofenac formulations in a vertical diffusion cell setup.
    Klein S
    Pharmazie; 2013 Jul; 68(7):565-71. PubMed ID: 23923638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Drug Release from Manipulated Abuse Deterrent Formulations.
    Feng X; Zidan A; Kamal NS; Xu X; Sun D; Walenga R; Boyce H; Cruz CN; Ashraf M
    AAPS PharmSciTech; 2020 Jan; 21(2):40. PubMed ID: 31897805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.